|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.00 PLN | -0.17% |
|
-2.12% | -11.89% |
| May. 27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| May. 15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 198.2 | +64.89% | 1 | ||||
| 56.55 | -4.52% | 11 | ||||||
| 22 | -0.45% | 7 | ||||||
| - | - | 48.3 | +27% | 1 | ||||
| 8.8 | +88.84% | 10 | ||||||
| 33 | -18.2% | 5 | ||||||
| 5.9 | -16.78% | 5 | ||||||
| - | 44,500 | +55.87% | 2 | |||||
| 8.333 | +76.93% | 3 | ||||||
| Average | 4,986.79 | +30.40% | 5 | ||||||
| Weighted average by Cap. | 2,365.15 | +13.84% | 7 |
- Stock Market
- Stocks
- SCP Stock
- Sector Scope Fluidics S.A.
- Sector consensus
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
